The offer is at a substantial premium with committed financing and unanimous board support suggests a high probability of completion. Monitor the BaFin clearance timeline and the EGM vote on post-closing measures; any competing bids or regulatory hurdles could delay the mid-2025 timeline.
Price Chart
Executive Summary
EQT Private Equity, alongside ADIA and CPP Investments, announced a recommended all-cash public takeover offer for QIAGEN at €46.50 per share, representing a 40.3% premium to the unaffected share price. The transaction values QIAGEN at approximately €10.8 billion enterprise value (~$12.1 billion including ~$1.1 billion net debt). The QIAGEN Boards unanimously recommend acceptance, with closing expected in mid-2027 subject to a 50% minimum acceptance threshold and regulatory clearances.
Key Financial Metrics
Key Facts
- All-cash offer at €46.50 per share, a 40.3% premium to the unaffected XETRA closing price of €33.15 on 8 July 2026
- Enterprise value of approximately €10.8 billion (~$12.1 billion including ~$1.1 billion net debt)
- Minimum acceptance threshold of 50% of outstanding share capital plus one share
- Closing expected in mid-2027, subject to merger control and foreign investment clearances
- Financing is committed and not subject to any financing condition; no financing condition
- Post-closing measures will result in full ownership transfer and delisting from FSE and NYSE
- Interim dividend of up to $0.47 per share if closing delayed beyond 10 months due to pending regulatory approvals
Financial Impact
€10.8 billion enterprise value (~$12.1 billion); offer price €46.50/share cash
Risk Factors
- Regulatory clearances (merger control, foreign investment) may delay or block the transaction
- Minimum acceptance threshold of 50% plus one share may not be met if shareholders hold out for higher price
- Shareholders who do not tender may receive a lower net amount due to withholding tax on post-closing measures
- Potential competing offers or alternative strategic proposals could emerge
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC TO-C Filing (Primary) | 0001104659-26-117921 |
| Document: tm2628053d1_ex99-1.htm | 0001104659-26-117921 |
| Document: tm2628053d1_sctoc.htm | 0001104659-26-117921 |
| Document: 0001104659-26-117921-index-headers.html | 0001104659-26-117921 |
| Document: 0001104659-26-117921-index.html | 0001104659-26-117921 |
| Document: 0001104659-26-117921.txt | 0001104659-26-117921 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 5d ago | 6-K | $50.39 $50.37 | ▼ −0.04% | ▼ −0.75% | $50.26 (−0.25%) |
Oct 22, 2026 6d ago | SC TO-C | $50.22 $50.39 | ▲ +0.34% | ▲ +0.86% | $50.26 (+0.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers